4-((5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbamoyl)benzoic acid, 95.0%, 50mg

2-Tridecanol>98.0%(GC)5g

Necrostatin-1, 95.0%, 250mg

2-Methyl-4-(1,1,1,2,3,3,3-heptafluoro-2-propyl)aniline, 95.0%, 10g

(S)-4-Benzyl-2-((benzyloxy)methyl)-1,4-oxazepane, 98%, 1g

Syringe filters Hydrophilic polytetrafluoroethylene (PTFE), 0,22 µm, 25 mm, Non-sterile, 100 Piece(s)

rac-(4aS,7aR)-4-methylhexahydropyrrolo[3,4-b][1,4]oxazin-3(2H)-one, 95.0%, 250mg

3-amino-1H-indazole-5-carboxylic acid, 97%, 250mg

4-Bromo-5-chloro-2-fluoropyridine, 95.0%, 5g

1-(3-Bromobenzyl)-1H-pyrazol-5-amine, 1g

3-(Trifluoromethyl)cyclobutan-1-amine hydrochloride, 97%, 5g

(3R,11bR)-3-Isobutyl-9,10-dimethoxy-3,4,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinolin-2(11bH)-one, 95.0%, 10mg

Bis(2-chloroethyl) carbonate, 98%, 10g